Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia

REFERENCES

• Adkins, J.E.; Boyer, E.W. & McCurdy, C.R. 2011. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry 11: 1165–1175.
   PubMed Web of Science ®Google Scholar
• Ahmad, K. & Aziz, Z. 2012. Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacology 141: 446–450.
   PubMed Web of Science ®Google Scholar
• Arndt, T.; Claussen, U.; Güssregen, B.; Schröfel, S.; Stürzer, B.; Werle, A. & Wolf, G. 2011. Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer. Forensic Science International 208: 47–52.
   PubMed Web of Science ®Google Scholar
• Assanangkornchai, S.; Muekthong, A.; Samangsri, N. & Pattanasattayawong, U. 2007. The use of Mitragynine speciosa (krathom), an addictive plant in Thailand. Substance Use and Misuse 42: 2145–2157.
   PubMed Web of Science ®Google Scholar
• Babu, K.M.; McCurdy, C.R. & Boyer, E.W. 2008. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clinical Toxicology (Philadelphia) 46 (2): 146–152.
   PubMed Web of Science ®Google Scholar
• Bernama. 2013. Household income continues to soar on economic transformation. The Star 31 March 2013. http://www.thestar.com.my/news/nation/2013/03/31/household-income-continues-to-soar-on-economic-transformation
   Google Scholar
• Bilinski, P.; Kapka-Skrzypczak, L. & Jablonski, P. 2012. Determining the scale of designer drugs (DD) abuse and risk to public health in Poland through an epidemiological study in adolescents. Annals of Agricultural and Environmental Medicine 19 (3): 357–364.
   PubMed Web of Science ®Google Scholar
• Boyer, E.W.; Babu, K.M.; Adkins, J.E.; McCurdy, C.R. & Halpern, J.H. 2008. Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa korth.). Addiction 103: 1048–1050.
   PubMed Web of Science ®Google Scholar
• Boyer, E.W.; Babu, K.M.; Macalino, G.E. & Compton, W. 2007. Self-treatment of opioid withdrawal with dietary supplement, kratom. American Journal of Addiction 16: 352–356.
   PubMed Web of Science ®Google Scholar
• Cornara, L.; Borghesi, B.; Canali, C.; Andrenacci, M.; Basso, M.; Federici, S. & Labra, M. 2013. Smart drugs: Green shuttle or real drug? International Journal of Legal Medicine 127: 1109–1123.
   PubMed Web of Science ®Google Scholar
• Dresen, S.; Ferreirós, N.; Pütz, M.; Westphal, F.; Zimmermann, R. & Auwärter, V. 2010. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectrometry 45: 1095–1232.
   PubMed Web of Science ®Google Scholar
• Dresen, S.; Ferreirós, M.; Pütz, M.; Westphal, F.; Zimmermann, R.; Auwärter, V. & Forrester, M.B. 2013. Kratom exposures reported to Texas poison centers. Journal of Addictive Disorders 32: 396–400.
   PubMed Web of Science ®Google Scholar
• Forrester, M.B. 2013. Kratom exposures reported to Texas poison centers. Journal of Addictive Diseases 32: 396–400.
   PubMed Web of Science ®Google Scholar
• Hassan, Z.; Muzaimi, M.; Navaratnam, V.; Yusoff, N.H.; Suhaimi, F.W.; Vadivelu, R.; Vicknasingam, B.K.; Amato, D.; von Hörsten, S.; Ismail, N.I.; Jayabalan, N.; Hazim, A.I.; Mansor, S.M. & Müller, C.P. 2013. From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews 37: 138–151.
   PubMed Web of Science ®Google Scholar
• Havemann-Reinecke, U. 2011. Kratom and alcohol dependence: Clinical symptoms, withdrawal treatment and pharmacological mechanisms: A case report. European Psychiatry 26 (Suppl. 1): 01–50.
   Google Scholar
• Helander, A.; Beck, O.; Hagerkvist, R. & Hulten, P. 2013. Identification of novel psychoactive drug use in Sweden based on laboratory analysis: Initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation 1–7.
   Web of Science ®Google Scholar
• Holler, J.M.; Vorce, S.P.; McDonough-Bender, P.C.; Magluilo, Jr., Solomon C.J. & Levine, B. 2011. A drug toxicity death involving propylhexedrine and mitragynine. Journal of Analytical Toxicology 35: 54–59.
   PubMed Web of Science ®Google Scholar
• Idayu, F.N.; Taufik Hidayat, M.; Moklas, M.A.M.; Sharida, F.; Nurul Raudzah, A.R.; Shamima, A.R. & Apryani, E. 2011. Antidepressant-like effects of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 18 (5): 402–407.
   PubMed Web of Science ®Google Scholar
• Jansen, K.L.R. & Prast, C. 1988a. Ethnopharmacology of kratom and the Mitragyna alkaloids. Journal of Ethnopharmacology 23: 115–119.
   PubMed Web of Science ®Google Scholar
• Johnson, L.A.; Johnson, R.L. & Portier, R.B. 2013. Current “legal highs.” Journal of Emergency Medicine 44 (6): 1108–1115.
   PubMed Web of Science ®Google Scholar
• Kapp, F.G.; Maurer, H.H.; Auwärter, V.; Winkelmann, M. & Hermanns-Clausen, M. 2011. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). Journal of Medical Toxicology 7: 227–231.
   PubMedGoogle Scholar
• Khor, B.S.; Amar Jamil, M.F.; Adenan, M.I. & Chong Shu-Chien, A. 2011. Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS ONE 6: e28340.
   PubMed Web of Science ®Google Scholar
• Kroonstad, R.; Roman, M.; Thelander, G. & Eriksson, A. 2011. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. Journal of Analytical Toxicology 35 (4): 242–247.
   PubMed Web of Science ®Google Scholar
• Logan, B.K.; Reinhold, L.E.; Xu, A. & Diamond, F.X. 2012. Identification of synthetic cannabinoids in herbal incense blends in the United States. Journal of Forensic Sciences 57: 1168–1180.
   PubMed Web of Science ®Google Scholar
• McLellan, A.T.; Luborsky, L.; Woody, G.E. & O’Brien, C.P. 1980. An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease 168: 26–33.
   PubMed Web of Science ®Google Scholar
• McWhirter, L. & Morris, S. 2010. A case report if inpatient detoxification after kratom (Mitragyna speciosa) dependence. European Addiction Research 16: 229–231.
   Google Scholar
• Müller, C.P. & Schumann, G. 2011a. Drugs as instruments: A new framework for non-addictive psychoactive drug use. Behavioral and Brain Sciences 34: 293–310.
   PubMed Web of Science ®Google Scholar
• Müller, C.P. & Schumann, G. 2011b. To use or not to use: Expanding the view on non-addictive psychoactive drug consumption and its implications. Behavioral and Brain Sciences 34: 328–347.
   PubMed Web of Science ®Google Scholar
• Neerman, M.F.; Frost, R.E. & Deking, J. 2013. A drug fatality involving kratom. Journal of Forensic Sciences 58 (Suppl. 1): S278–S279.
   PubMed Web of Science ®Google Scholar
• Nelsen, J.L.; Lapoint, J.; Hodgman, M.J. & Aldous, K.M. 2010. Seizure and coma following kratom (Mitragyna speciosa Korth) exposure. Journal of Medical Toxicology 6 (4): 424–426.
   PubMedGoogle Scholar
• Prozialeck, W.C.; Jivan, J.K. & Andurkar, S.V. 2012. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association 112 (12): 792–799.
   PubMedGoogle Scholar
• Rosenbaum, C.D.; Carreiro, S.P. & Babu, K.M. 2012. Here today, gone tomorrow and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology 8: 15–32.
   PubMedGoogle Scholar
• Saingam, D.; Assanangkornchai, S.; Geater, A.F. & Balthip, Q. 2013. Pattern and consequences of krathom (Mitragyna speciosa korth.) use among male villagers in southern Thailand: A qualitative study. International Journal of Drug Policy 24: 351–358.
   PubMed Web of Science ®Google Scholar
• Sheleg, S.V. & Collins, G.B. 2011. A coincidence of addiction to Kratom and severe primary hypothyroidism. Journal of Addiction Medicine 5 (4): 300–301.
   PubMed Web of Science ®Google Scholar
• Singh, D.; Müller, C.P. & Vicknasingam, B. 2014. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139: 132–137.
   PubMed Web of Science ®Google Scholar
• Stolt, A.C.; Schroder, H.; Neurath, H.; Grecksch, G.; Holl, V.; Meyer, M.R.; Maurer, H.H.; Ziebolz, N.; Havemann-Reinecke, U. & Becker, A. 2013. Behavioural and neurochemical characterization of kratom (Mitragyna speciosa) extract. Psychopharmacology 231: 13–25.
   PubMed Web of Science ®Google Scholar
• Suwanlert, S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27: 21–27.
   PubMedGoogle Scholar
• Thuan, L.C. 1957. Addiction to Mitragyna speciosa. In: Proceedings of the Alumni Association, vol. 10, University Malaya, Kuala Lumpur; 322–324.
   Google Scholar
• Trakulsrichai, S.; Tongpo, A.; Sriapha, C.; Wongvisawakorn, S.; Rittilert, P.; Kaojarern Wananukul, W. 2013. Kratom abuse in Ramathibodi Poison Center, Thailand: A five-year experience. Journal of Psychoactive Drugs 45 (5): 404–408.
   PubMed Web of Science ®Google Scholar
• Vicknasingam, B.; Narayanan, S.; Beng, G.T. & Mansor, S.M. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21: 283–288.
   PubMed Web of Science ®Google Scholar
• Ward, J.; Rosenbaum, C.; Hernon, C.; McCurdy, C.R. & Boyer, E.W. 2011. Herbal medicines for the management of opioid addiction: Safe and effective alternatives to conventional pharmacotherapy? CNS Drugs 25: 999–1007.
   PubMed Web of Science ®Google Scholar
• Watanabe, K.; Yano, S.; Horie, S. & Yamamoto, L.T. 1997. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guine-pig ileum through the opioid receptor. Life Sciences 60 (12): 933–942.
   PubMed Web of Science ®Google Scholar
• Yusoff, N.H.M.; Suhaimi, F.W.; Vadivelu, R.K.; Hassan, Z.; Rumler, A.; Rotter, A.; Amato, D.; Dringenberg, H.; Mansor, S.M.; Navaratnam, V. & Müller, C.P. 2014. Abuse potential and adverse cognitive effects of mitragynine (kratom) in rats. Addiction Biology (in press).
   Google Scholar